June 20 2012 MicroDose Therapeutx and Moerae Matrix Announce Collaboration to Develop Novel Inhaled Treatment for Idiopathic Pulmonary Fibrosis (IPF)

MONMOUTH JUNCTION, N.J.–()–MicroDose       Therapeutx, Inc. and Moerae       Matrix, Inc. announced today that they have signed a collaboration       agreement to develop a dry powder inhalation product of Moerae’s novel MK2 inhibitor, MMI-0100, for the treatment of idiopathic pulmonary fibrosis (IPF), a serious and fatal lung disease for which there are no approved treatments in the U.S. The collaboration will involve the development and supply of a pulmonary drug delivery system for Moerae       and/or its partners utilizing MicroDose’s proprietary inhaler technology in support of chronic administration.

“We are pleased to be partnering with a recognized industry leader in pulmonary drug delivery to advance development of MMI-0100 for IPF,” said Cynthia Lander, PhD, Chairman and Chief Executive Officer of Moerae Matrix. “MicroDose’s piezo-driven dry powder inhaler platform is the optimal technology for delivering our first-in-class peptide therapeutic for treatment of IPF.”

Commenting from MicroDose, Scott Fleming, Sr. Vice President, Sales and Marketing said, “Moerae has assembled an impressive team to advance this promising treatment approach for this debilitating disease and we are pleased to be able to contribute to its advancement. This collaboration in IPF expands the utilization of MicroDose’s inhalation technology into yet another extremely important disease area.”

Read the entire article at:

http://www.businesswire.com/news/home/20120620005453/en/MicroDose-Therapeutx-Moerae-Matrix-Announce-Collaboration-Develop

For more information about Idiopathic Pulmonary Fibrosis please visit: www.ipftoday.com

 

This entry was posted in Interstitial Lung Disease, IPF, Medical, Pulmonary Fibrosis, Uncategorized and tagged , , , , , , , . Bookmark the permalink.

One Response to June 20 2012 MicroDose Therapeutx and Moerae Matrix Announce Collaboration to Develop Novel Inhaled Treatment for Idiopathic Pulmonary Fibrosis (IPF)

  1. Thanks for another informative site. Where else may I am
    getting that type of information written in such a perfect manner?

    I’ve a venture that I’m just now working on,
    and I’ve been at the glance out for such info.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>